ArticleThoracic cancer2024

Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies.

Hiroyuki Kozai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.